Discussing a T2D Medication That Could Reduce Insulin Needs in T1D

Diabetes Discourse by ReachMD

Nov 27, 202300:11:30Science & Medicine

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could al...

Related Episodes

Continue listening to more episodes from Diabetes Discourse.

Diabetes and CKD: Strategies for Diagnosis and Treatment

May 21, 2024 - 00:11:00

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ian de Boer, MD Since up to 40 percent of pa...

Uncovering the Prevalence of Type 1 Diabetes in Older Adults

May 9, 2024 - 00:07:30

Guest: Elena Toschi, MD Approximately over the last decade, lifespans in the general population have incr...

Concentrating on the MOMPOD Trial for Metformin Plus Insulin

Apr 12, 2024 - 00:10:30

Host: John Buse, MD, PhD Guest: Kim Boggess, MD The most common forms of diabetes encountered in pregnant...

Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients

Apr 9, 2024 - 00:07:00

Guest: R. Paul Wadwa, M.D. Since young kids have a different activity level and diet than older kids or a...

Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients

Apr 8, 2024 - 00:11:30

Host: Carol Wysham Guest: A. Michael Lincoff, MD Given the growing evidence that obesity is associated wi...

Overcoming Obesity: Insights from the SURMOUNT-4 Trial

Mar 27, 2024 - 00:12:30

Host: John Buse, MD, PhD Guest: Louis J. Aronne, MD, FTOS In the SURMOUNT-4 trial, 100 patients with obes...

Strategies for Addressing Diabetes Stigma and Discrimination

Feb 1, 2024 - 00:11:00

Host: John Buse, MD, PhD Guest: Mary de Groot, PhD The prevalence of diabetes-related stigma is alarmingl...

How the Artificial Pancreas Can Help Diabetic Patients

Dec 20, 2023 - 00:03:00

Host: Stuart Weinzimer, MD The artificial pancreas represents the integration of two separate devices: a...